Principia Biopharma Receives $12,500,000 Series B Funding Round

  • Feed Type
  • Date
    10/29/2012
  • Company Name
    Principia Biopharma
  • Mailing Address
    Undisclosed Menlo Park, CA 94025
  • Company Description
    The compnay develops unspecified biotheraputic products.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $12,500,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds from this most recent financing will be used to advance Principia’s lead molecule towards the clinic and to develop additional programs enabled by the company’s reversible covalent platform.
  • M&A Terms
  • Venture Investor
    New Leaf Venture Partners
  • Venture Investor
    OrbiMed Advisors
  • Venture Investor
    Morgenthaler Ventures
  • Venture Investor
    SR One
  • Venture Investor
    Mission Bay Capital

By posting a comment, you agree to our terms and conditions.